Celine M. Vachon

32.7k total citations · 2 hit papers
269 papers, 9.6k citations indexed

About

Celine M. Vachon is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Celine M. Vachon has authored 269 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Oncology, 92 papers in Pulmonary and Respiratory Medicine and 75 papers in Cancer Research. Recurrent topics in Celine M. Vachon's work include Digital Radiography and Breast Imaging (89 papers), Global Cancer Incidence and Screening (77 papers) and AI in cancer detection (65 papers). Celine M. Vachon is often cited by papers focused on Digital Radiography and Breast Imaging (89 papers), Global Cancer Incidence and Screening (77 papers) and AI in cancer detection (65 papers). Celine M. Vachon collaborates with scholars based in United States, Canada and Belarus. Celine M. Vachon's co-authors include Thomas A. Sellers, V. Shane Pankratz, Robert A. Vierkant, James R. Cerhan, Kathleen R. Brandt, Christopher G. Scott, Karthik Ghosh, Karla Kerlikowske, Lynn C. Hartmann and Daniel W. Visscher and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Celine M. Vachon

256 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benign Breast Disease and the Risk of Breast Cancer

2005 628 citations Thomas A. Sellers, Marlene H. Frost et al. profile →
Unsupervised Deep Learning Applied to Breast Density Segmentation and Mammographic Risk Scoring

2016 319 citations Celine M. Vachon et al. profile →

Peers

Countries citing papers authored by Celine M. Vachon

Since Specialization

Citations

This map shows the geographic impact of Celine M. Vachon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celine M. Vachon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celine M. Vachon more than expected).

Fields of papers citing papers by Celine M. Vachon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celine M. Vachon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celine M. Vachon. The network helps show where Celine M. Vachon may publish in the future.

Co-authorship network of co-authors of Celine M. Vachon

This figure shows the co-authorship network connecting the top 25 collaborators of Celine M. Vachon. A scholar is included among the top collaborators of Celine M. Vachon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celine M. Vachon. Celine M. Vachon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature 2024 ·Blood ·(unknown), Brian Giacopelli, Kari G. Rabe, (unknown), Yue-Zhong Wu, Huihuang Yan, Tait D. Shanafelt, Sameer A. Parikh, Wei Ding, Paul J. Hampel, (unknown), James R. Cerhan, Celine M. Vachon, Neil E. Kay, Curtis A. Hanson, Alexander S. Parker, Esteban Braggio, Susan L. Slager, Christopher C. Oakes	2
2	Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up 2023 ·Cancer Prevention Research ·Daniela Stan, (unknown), Daniel J. Schaid, Erin E. Carlson, Christina Kim, Jason P. Sinnwell, Fergus J. Couch, Celine M. Vachon, Andrew Cooke, Benjamin A. Goldenberg, Sandhya Pruthi	1
3	A Clinical Risk Model for Personalized Screening and Prevention of Breast Cancer 2023 ·Cancers ·Mikael Eriksson, Kamila Czene, Celine M. Vachon, Emily F. Conant, Per Hall	8
4	Association of breast cancer risk, density, and stiffness: global tissue stiffness on breast MR elastography (MRE) 2022 ·Breast Cancer Research and Treatment ·Bhavika Patel, Kay Pepin, Kathy R. Brandt, Gina L. Mazza, Barbara A. Pockaj, Jun Chen, Yuxiang Zhou, Donald W. Northfelt, Karen Anderson, Juliana M. Kling, Celine M. Vachon, Kristin R. Swanson, Mehdi Nikkhah, Richard L. Ehman	20
5	Surveillance mammography after treatment for male breast cancer 2022 ·Breast Cancer Research and Treatment ·Siddhartha Yadav, Lindsey R. Sangaralingham, Stephanie Payne, Karthik V. Giridhar, Tina J. Hieken, Judy C. Boughey, Robert W. Mutter, John R. Hawse, Rafael E. Jiménez, Rachel A. Freedman, (unknown), Fergus J. Couch, Celine M. Vachon, Nilay D. Shah, Roberto A. Leon‐Ferre, Kathryn J. Ruddy	1
6	Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries 2021 ·International Journal of Epidemiology ·Amber N. Hurson, Parichoy Pal Choudhury, Chi Gao, Anika Hüsing, Mikael Eriksson, Min Shi, Michael E. Jones, D. Gareth Evans, Roger L. Milne, Mia M. Gaudet, Celine M. Vachon, Daniel I. Chasman, Douglas F. Easton, Marjanka K. Schmidt, Peter Kraft, Montserrat García‐Closas, Nilanjan Chatterjee, (unknown)	43
7	Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis 2021 ·Leukemia ·Alissa Visram, Celine M. Vachon, Linda B. Baughn, Dirk R. Larson, James B. Smadbeck, Angela Dispenzieri, Prashant Kapoor, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Taxiarchis Kourelis, Wilson I. Gonsalves, Rahma Warsame, Eli Muchtar, Nelson Leung, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar	4
8	Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy 2020 ·Cancer Prevention Research ·Mark E. Sherman, Robert A. Vierkant, (unknown), Tanya L. Hoskin, Marlene H. Frost, (unknown), Daniel W. Visscher, Jodi M. Carter, Stacey J. Winham, Matthew R. Jensen, Derek C. Radisky, Celine M. Vachon, Amy C. Degnim	9
9	Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake 2020 ·Cancer Prevention Research ·(unknown), Daniel J. Schaid, Celine M. Vachon, Andrew Cooke, Fergus J. Couch, Christina Kim, Jason P. Sinnwell, Linda Hasadsri, Daniela Stan, Benjamin A. Goldenberg, Lonzetta Neal, Debjani Grenier, Amy C. Degnim, (unknown), Sandhya Pruthi	10
10	Longitudinal Changes in Volumetric Breast Density in Healthy Women across the Menopausal Transition 2019 ·Cancer Epidemiology Biomarkers & Prevention ·Natalie J. Engmann, Christopher G. Scott, Matthew R. Jensen, Stacey J. Winham, Lin Ma, Kathleen R. Brandt, Amir Pasha Mahmoudzadeh, Dana H. Whaley, Carrie B. Hruska, Fang-Fang Wu, Aaron D. Norman, Robert A. Hiatt, John Heine, John Shepherd, V. Shane Pankratz, Diana L. Miglioretti, Karla Kerlikowske, Celine M. Vachon	16
11	Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement 2019 ·Blood Cancer Journal ·David Murray, Shaji Kumar, Robert A. Kyle, Angela Dispenzieri, Surendra Dasari, Dirk R. Larson, Celine M. Vachon, James R. Cerhan, S. Vincent Rajkumar	56
12	Radiomic Phenotypes of Mammographic Parenchymal Complexity: Toward Augmenting Breast Density in Breast Cancer Risk Assessment 2018 ·Radiology ·Despina Kontos, Stacey J. Winham, Andrew Oustimov, Lauren Pantalone, (unknown), Aimilia Gastounioti, Dana H. Whaley, Carrie B. Hruska, Karla Kerlikowske, Kathleen R. Brandt, Emily F. Conant, Celine M. Vachon	56
13	Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development 2017 ·Clinical Cancer Research ·Amy C. Degnim, Tanya L. Hoskin, (unknown), Marlene H. Frost, Stacey J. Winham, (unknown), (unknown), Jodi M. Carter, Melody Stallings‐Mann, Linda M. Murphy, Erin Miller, (unknown), Celine M. Vachon, Keith L. Knutson, Derek C. Radisky, Daniel W. Visscher	46
14	Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Natalie J. Engmann, Christopher G. Scott, Matthew R. Jensen, Lin Ma, Kathleen R. Brandt, Amir Pasha Mahmoudzadeh, Serghei Malkov, Dana H. Whaley, Carrie B. Hruska, Fang Wu, Stacey J. Winham, Diana L. Miglioretti, Aaron D. Norman, John Heine, John Shepherd, V. Shane Pankratz, Celine M. Vachon, Karla Kerlikowske	36
15	Mapping of the IRF8 Gene Identifies a 3′UTR Variant Associated with Risk of Chronic Lymphocytic Leukemia but not Other Common Non-Hodgkin Lymphoma Subtypes 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Susan L. Slager, Sara J. Achenbach, Yan W. Asmann, Nicola J. Camp, Kari G. Rabe, Lynn R. Goldin, Timothy G. Call, Tait D. Shanafelt, Neil E. Kay, Julie M. Cunningham, Alice H. Wang, J. Brice Weinberg, Aaron D. Norman, Brian K. Link, José F. Leis, Celine M. Vachon, Mark C. Lanasa, Neil E. Caporaso, Anne J. Novak, James R. Cerhan	12
16	Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use 2010 ·Journal of Clinical Oncology ·Karla Kerlikowske, Andrea J. Cook, Diana S.M. Buist, Steve Cummings, Celine M. Vachon, Pamela M. Vacek, Diana L. Miglioretti	164
17	Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance 2009 ·Blood ·Celine M. Vachon, Robert A. Kyle, Terry M. Therneau, (unknown), Dirk R. Larson, Colin Colby, (unknown), Angela Dispenzieri, Shaji Kumar, Jerry A. Katzmann, S. Vincent Rajkumar	87
18	Allergic Pulmonary Inflammation Promotes the Recruitment of Circulating Tumor Cells to the Lung 2008 ·Cancer Research ·Anna G. Taranova, David R. Maldonado, Celine M. Vachon, Elizabeth A. Jacobsen, Hiam Abdala‐Valencia, Michael P. McGarry, Sergei I. Ochkur, Cheryl Protheroe, Alfred D. Doyle, Clive S. Grant, Joan M. Cook‐Mills, Lutz Birnbaumer, Nancy A. Lee, James J. Lee	47
19	Strong Evidence of a Genetic Determinant for Mammographic Density, a Major Risk Factor for Breast Cancer 2007 ·Cancer Research ·Celine M. Vachon, Thomas A. Sellers, Erin E. Carlson, Julie M. Cunningham, Christopher A. Hilker, Regenia L. Smalley, Daniel J. Schaid, Linda E. Kelemen, Fergus J. Couch, V. Shane Pankratz	58
20	Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. 2000 ·PubMed ·Celine M. Vachon, Lawrence H. Kushi, James R. Cerhan, Christopher C. Kuni, Thomas A. Sellers	136

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact